Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H16N2O |
Molecular Weight | 216.2789 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C(OC1=C(C=CC=C1)C2CC2)C3=NCCN3
InChI
InChIKey=YAORIDZYZDUZCM-UHFFFAOYSA-N
InChI=1S/C13H16N2O/c1-2-4-12(11(3-1)10-5-6-10)16-9-13-14-7-8-15-13/h1-4,10H,5-9H2,(H,14,15)
Molecular Formula | C13H16N2O |
Molecular Weight | 216.2789 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Cirazoline is an agonist of alpha1A adrenergic receptor, a partial agonist of alpha1B and alpha1D receptors, and an antagonist of alpha2 adrenergic receptors. Cirazoline was used to study the biologic function of adrenergic receptors. Injection of cirazoline into to the paravenricular hypothalamic nucleus of rats suppressed food and water intake. Cirazoline caused a large renal vasopressor response in rats. Systemic administration of cirazoline impaired spatial working memory in monkeys.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL229 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8564227 |
120.0 nM [Ki] | ||
Target ID: CHEMBL232 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8564227 |
960.0 nM [Ki] | ||
Target ID: CHEMBL223 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8564227 |
660.0 nM [Ki] |
PubMed
Title | Date | PubMed |
---|---|---|
Receptor interactions of imidazolines. IX. Cirazoline is an alpha-1 adrenergic agonist and an alpha-2 adrenergic antagonist. | 1982 Jul |
|
Effects of staurosporine on the pressor responses to alpha-adrenoceptor agonists in pithed rats: a comparison with nifedipine. | 1991 |
|
Effects on ingestive behavior in rats of the alpha 1-adrenoceptor agonist cirazoline. | 1992 Jan 7 |
|
Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. | 1994 Nov |
|
Selectivity of the imidazoline alpha-adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned alpha 1-adrenoceptor subtypes. | 1995 Sep |
|
Adrenergic stimulation of lipoprotein lipase gene expression in rat brown adipocytes differentiated in culture: mediation via beta3- and alpha1-adrenergic receptors. | 1997 Feb 1 |
|
The release of noradrenaline in the locus coeruleus and prefrontal cortex studied with dual-probe microdialysis. | 2001 Jul 6 |
|
Phe-308 and Phe-312 in transmembrane domain 7 are major sites of alpha 1-adrenergic receptor antagonist binding. Imidazoline agonists bind like antagonists. | 2001 Jul 6 |
|
[Excitatory effect of noradrenaline on rat airway parasympathetic ganglion neurons]. | 2001 Nov |
|
Effect of nitric oxide synthase inhibitor N(omega) nitro-L-arginine methyl ester on relaxant responses to calcium channel antagonists in isolated aortic rings from Dahl normotensive and hypertensive rats. | 2002 Mar |
|
Identification and characterization of the imidazoline I2b-binding sites in the hamster brown adipose tissue as a study model for imidazoline receptors. | 2003 Apr |
|
Identification and pharmacological characterization of a specific agmatine transport system in human tumor cell lines. | 2003 Dec |
|
Opposite effects of alpha 1- and beta-adrenoceptor stimulation on both glutamate- and gamma-aminobutyric acid-mediated spontaneous transmission in cultured rat hippocampal neurons. | 2003 Feb 15 |
|
Contractile actions of imidazoline alpha-adrenoceptor agonists and effects of noncompetitive alpha1-adrenoceptor antagonists in human vas deferens. | 2003 Feb 21 |
|
A photosensitive vascular smooth muscle store of nitric oxide in mouse aorta: no dependence on expression of endothelial nitric oxide synthase. | 2003 Mar |
|
Stimulation of alpha1-adrenoceptors in the rat medial prefrontal cortex increases the local in vivo 5-hydroxytryptamine release: reversal by antipsychotic drugs. | 2003 Nov |
|
Tempol, an antioxidant, restores endothelium-derived hyperpolarizing factor-mediated vasodilation during hypertension. | 2003 Nov 14 |
|
Regulation of the release of serotonin in the dorsal raphe nucleus by alpha1 and alpha2 adrenoceptors. | 2003 Oct |
|
Noradrenaline inhibits autonomous activity in the isolated guinea pig bladder. | 2004 Feb |
|
Preoptic alpha 1- and alpha 2-noradrenergic agonists induce, respectively, PGE2-independent and PGE2-dependent hyperthermic responses in guinea pigs. | 2004 Jun |
|
Allosteric modulation of semicarbazide-sensitive amine oxidase activities in vitro by imidazoline receptor ligands. | 2004 Oct |
|
Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. | 2004 Oct 29 |
|
Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist. | 2004 Sep |
|
alpha1A-adrenoceptors activate glucose uptake in L6 muscle cells through a phospholipase C-, phosphatidylinositol-3 kinase-, and atypical protein kinase C-dependent pathway. | 2005 Feb |
|
Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors. | 2005 Jul |
|
Addition of a signal peptide sequence to the alpha1D-adrenoceptor gene increases the density of receptors, as determined by [3H]-prazosin binding in the membranes. | 2005 Mar |
|
Increased Rho activation and PKC-mediated smooth muscle contractility in the absence of caveolin-1. | 2006 Dec |
|
Presynaptic alpha1 adrenergic receptors differentially regulate synaptic glutamate and GABA release to hypothalamic presympathetic neurons. | 2006 Feb |
|
Discriminative stimulus properties of the selective and highly potent alpha2-adrenoceptor agonist, S18616, in rats: mediation by the alpha2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin. | 2006 Sep |
|
Medial prefrontal cortical alpha1 adrenoreceptor modulation of the nucleus accumbens dopamine response to stress in Long-Evans rats. | 2007 Apr |
|
Beta(2)-Adrenergic activation increases glycogen synthesis in L6 skeletal muscle cells through a signalling pathway independent of cyclic AMP. | 2007 Jan |
|
Mechanisms of modafinil: A review of current research. | 2007 Jun |
|
Presynaptic alpha-adrenoceptors in median preoptic nucleus modulate inhibitory neurotransmission from subfornical organ and organum vasculosum lamina terminalis. | 2007 May |
|
Alpha 1-adrenoceptor agonists protect against stress-induced death of neural progenitor cells. | 2007 Nov 14 |
|
Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions. | 2008 Apr 23 |
|
The adrenergic receptor subtypes present in frog (Rana esculenta) skin. | 2008 Aug |
|
Enhanced alpha1 adrenergic sensitivity in sensorimotor gating deficits in neonatal ventral hippocampus-lesioned rats. | 2008 Dec |
|
Effects of a Western diet versus high glucose on endothelium-dependent relaxation in murine micro- and macro-vasculature. | 2008 Dec 28 |
|
Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats. | 2008 Dec 5 |
|
Different response of ANP secretion to adrenoceptor stimulation in renal hypertensive rat atria. | 2008 Jul |
|
alpha(1A)- and alpha(1B)-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse. | 2009 Aug 18 |
|
Might adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? | 2009 Nov 26 |
|
Alpha1-adrenoceptors modulate citalopram-induced serotonin release. | 2010 Jun |
|
Modulation of N-type calcium currents by presynaptic imidazoline receptor activation in rat superior cervical ganglion neurons. | 2010 Oct |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:21:19 UTC 2023
by
admin
on
Sat Dec 16 16:21:19 UTC 2023
|
Record UNII |
QK318GVY3Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29709
Created by
admin on Sat Dec 16 16:21:20 UTC 2023 , Edited by admin on Sat Dec 16 16:21:20 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL13852
Created by
admin on Sat Dec 16 16:21:20 UTC 2023 , Edited by admin on Sat Dec 16 16:21:20 UTC 2023
|
PRIMARY | |||
|
SUB07478MIG
Created by
admin on Sat Dec 16 16:21:20 UTC 2023 , Edited by admin on Sat Dec 16 16:21:20 UTC 2023
|
PRIMARY | |||
|
59939-16-1
Created by
admin on Sat Dec 16 16:21:20 UTC 2023 , Edited by admin on Sat Dec 16 16:21:20 UTC 2023
|
PRIMARY | |||
|
DB09202
Created by
admin on Sat Dec 16 16:21:20 UTC 2023 , Edited by admin on Sat Dec 16 16:21:20 UTC 2023
|
PRIMARY | |||
|
C014282
Created by
admin on Sat Dec 16 16:21:20 UTC 2023 , Edited by admin on Sat Dec 16 16:21:20 UTC 2023
|
PRIMARY | |||
|
C77294
Created by
admin on Sat Dec 16 16:21:20 UTC 2023 , Edited by admin on Sat Dec 16 16:21:20 UTC 2023
|
PRIMARY | |||
|
DTXSID4045131
Created by
admin on Sat Dec 16 16:21:20 UTC 2023 , Edited by admin on Sat Dec 16 16:21:20 UTC 2023
|
PRIMARY | |||
|
2765
Created by
admin on Sat Dec 16 16:21:20 UTC 2023 , Edited by admin on Sat Dec 16 16:21:20 UTC 2023
|
PRIMARY | |||
|
CIRAZOLINE
Created by
admin on Sat Dec 16 16:21:20 UTC 2023 , Edited by admin on Sat Dec 16 16:21:20 UTC 2023
|
PRIMARY | |||
|
4221
Created by
admin on Sat Dec 16 16:21:20 UTC 2023 , Edited by admin on Sat Dec 16 16:21:20 UTC 2023
|
PRIMARY | |||
|
QK318GVY3Y
Created by
admin on Sat Dec 16 16:21:20 UTC 2023 , Edited by admin on Sat Dec 16 16:21:20 UTC 2023
|
PRIMARY | |||
|
100000081544
Created by
admin on Sat Dec 16 16:21:20 UTC 2023 , Edited by admin on Sat Dec 16 16:21:20 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST | |||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|